systemic-lupus-erythematosus

Documents about systemic-lupus-erythematosus

• Chronic Hydroxychloroquine Improves Endothelial Dysfunction and Protects Kidney in a Mouse Model of Systemic Lupus Erythematosus#626540Repositorio Institucional de la Universidad de Granada
• Characterization of Autoreactive b Lymphocytes in Autoimmune Diseases and Immune Deficiencies#841030ClinicalTrials.gov
• A Study to Learn More About the Safety and Effects of Felzartamab in Adults With Lupus Nephritis Aged 18 to 75 Years Old#966922ClinicalTrials.gov
• Universal CAR-T Cells (BRL-301) in Relapse or Refractory Autoimmune Diseases#867916ClinicalTrials.gov
• ERN ReCONNET–SLICC–SLEuro expert consensus on the therapeutic management of rare systemic lupus erythematosus manifestations#308177HAL (France)
• SLECA: A Single-Cell Atlas of Systemic Lupus Erythematosus Enabling Rare-Cell Discovery Using Graph Transformer.#368267NCBI PubMed Central
• Objective Measurement With TCM Pattern for AIDDES#836582ClinicalTrials.gov
• Phase I/II Study of AD-PluReceptor Plus Tafasitamab-cxix and Lymphodepleting Chemotherapy in Patients With Autoimmune Disorders#873895ClinicalTrials.gov
• Acute Motor Axonal Neuropathy (AMAN) Variant of Guillain-Barré Syndrome Following Influenza Vaccination as the Initial Presentation of Systemic Lupus Erythematosus With Lupus Nephritis.#382520NCBI PubMed Central
• The case for an Epstein-Barr virus vaccine: Lessons from its link to systemic lupus erythematosus.#13644NCBI PubMed Central
• Immunogenicity and Safety of a Quadrivalent Human Papillomavirus (HPV) Vaccine in Patients With SLE: a Controlled Study#127663ClinicalTrials.gov
• Diffuse Alveolar Hemorrhage in Systemic Lupus Erythematosus: An Updated Clinical Perspective on a High-Mortality Complication.#223035NCBI PubMed Central
• SAFETY, EFFICACY, AND IMMUNOGENICITY OF SARS-COV-2 MRNA VACCINES IN PATIENTS WITH SYSTEMIC LUPUS ERYTHEMATOSUS#334543ScholarBank@NUS
• Monitoring the IMmUological TOXicity of Drugs#857429ClinicalTrials.gov
• Human Papilloma Virus Vaccination and Chronic Inflammatory Rheumatic Diseases.#866722ClinicalTrials.gov
• Interferon Pathway Activation in Monogenic and Nonmonogenic Forms of Pediatric SLE#870264ClinicalTrials.gov
• Dose-escalation Trial of Anti-C5aR Antibody in Healthy Subjects#898947ClinicalTrials.gov
• Patient outcomes from implementing a shared decision-making aid for systemic lupus erythematosus: a prospective implementation study.#988528NCBI PubMed Central
• Safety and Efficacy Study of CD19-CAR-DNT Cells in Autoimmune Diseases#838214ClinicalTrials.gov
• Data Sheet 1_Circulating long non-coding RNAs as diagnostic markers of lupus nephritis and 5-year follow-up disease flares.docx#424581Figshare
• Assessment of long-term damage and cardiovascular risk in juvenile systemic lupus erythematosus compared to juvenile dermatomyositis in adulthood#151580bioRxiv / medRxiv
• Type I Interferon Signature Strength Correlates with Alloimmunization-Associated Transcriptomic Programs in Systemic Lupus Erythematosus: A Multi-Cohort Analysis#154930bioRxiv / medRxiv
• Meta-analysis of factors for osteonecrosis in systemic lupus erythematosus: integration of comprehensive literatures and multicenter databases.#378462NCBI PubMed Central
• T cell exhaustion: a two-sided blade in systemic lupus erythematosus, from molecular mechanisms to clinical translation.#402688NCBI PubMed Central
• MX2 and IRF7 are Associated With Disease Activity and Renal Involvement in Systemic Lupus Erythematosus: An Exploratory Study.#409387NCBI PubMed Central
• Hallucinations and Related Perceptual Phenomena in Systemic Lupus Erythematosus and Inflammatory Arthritis: A Cross-sectional Mixed-Methods Study#635081Goldsmiths Research Online
• Belimumab in SLE Synovial Inflammation and Lymph Nodes#827436ClinicalTrials.gov
• Efficacy of Faslodex in Treatment of SLE Clinical, Serologic, and Molecular Studies#844291ClinicalTrials.gov
• The 2019 EULAR/ACR Classification Criteria as Predictor of Organ Damage in Systemic Lupus Erythematosus Patients#853137ClinicalTrials.gov
• MRI Evaluation Assessing Synovitis to Address the Unmet Need for Reliable Endpoints in SLE#895287ClinicalTrials.gov
• Transcriptional and Immune Parameters of Response to Belimumab#969547ClinicalTrials.gov
• Clinical Study of EVM18001 in the Treatment of Refractory Autoimmune Diseases#801221ClinicalTrials.gov
• Anti-CD19-CD3E-CAR-T Cells in Relapsed/Refractory Autoimmune Disease#851290ClinicalTrials.gov
• Efficacy of valaciclovir in preventing herpes zoster in patients receiving anifrolumab#156363HAL (France)
• Statins May Not be Associated with a Reduction in Primary Cardiovascular Events in Patients with Systemic Lupus Erythematosus#410903bioRxiv / medRxiv
• COVID-19 Infection in Vulnerable Patients With Inflammatory Rheumatic Diseases#912774ClinicalTrials.gov
• An Investigational Study of Experimental Medication BMS-986165 in Healthy Participants to Study Electrocardiogram Effects#967456ClinicalTrials.gov
• Statins and Lupus: Effects of Statins on Clinical Lupus Parameters, Serological Markers and Toll-like Receptors#967530ClinicalTrials.gov
• Type I Interferon Signature Strength Correlates with Alloimmunization-Associated Transcriptomic Programs in Systemic Lupus Erythematosus: A Multi-Cohort Analysis#157814Unpaywall
• Immune network dysregulation in rheumatoid arthritis and systemic lupus erythematosus: cytokine signatures, autoantibody profiles, and implications for precision medicine.#418322NCBI PubMed Central
• Case Report: Overlapping multiple sclerosis and neuropsychiatric systemic lupus erythematosus with positive MOG-IgG: a case initially misdiagnosed as depression.#427583NCBI PubMed Central
• Describing flares: A mixed methods study comparing patient and clinician perspectives in systemic lupus erythematosus and other rheumatic diseases#629594Goldsmiths Research Online
• Employment and Arthritis: Making it Work#839147ClinicalTrials.gov
• The Therapeutic Value and Mechanism of Recombinant Human Interleukin-2 on Children With Rheumatic Diseases#853635ClinicalTrials.gov
• Study of Ultra-Fast BCMA/CD70 CAR-T Therapy for Refractory SLE#886275ClinicalTrials.gov
• Long-term association of the triglyceride-glucose index with cardiovascular involvement in systemic lupus erythematosus: a retrospective cohort study.#988404NCBI PubMed Central
• COVID-19 Booster Vaccine in Autoimmune Disease Non-Responders#217105ClinicalTrials.gov
• Study of Efficacy and Safety of LNP023 in Participants With Active Lupus Nephritis Class III-IV, +/- V#870100ClinicalTrials.gov
• KYSA-3: A Study of Anti-CD19 Chimeric Antigen Receptor T-Cell (CD19 CAR T) Therapy, in Subjects With Refractory Lupus Nephritis#847923ClinicalTrials.gov
• Comparison of Evans syndrome and isolated autoimmune cytopenias in SLE: a retrospective study#15458HAL (France)